Member Info for doggo

Current unofficial mid-raise value is ~$700 million.

We’ve come down on anyone who promotes another stock. It’s just not cricket.

We’ve all been tolerating each other lately..don’t spoil it Rich.

Clown.... Stop ramping SNG there’s a placing coming there plain as day.

if Factom fails to complete a financing, then the Purchase Amount will be converted to shares of a new series of preferred stock at a default price per share on the terms set forth in the SAFE agreement;

- the SAFE Agreement includes certain situations where the Long-Stop Date can be extended by 90 days to finalize and close definitive transaction documents

Results are likely being held back for the above event as it will dramatically increase the NAV on a post results update RNS.
Series B delay should mean an excellent uplift due to default price as I can’t imagine this would be for less equity than we were receiving via Series B and should be significantly more. Hence any subsequent series B will give our valuation a super boost.

They’ve made it clear that certain PF companies will either IPO or be sold this year. They are the IPO specialists

I’m fairly certain that DI dismisses the offer immediately. They are a Japan Stock Exchange listed company and it didn’t RNS the offer

No I’m saying that the largest shareholders in Yooya were unwilling to sell.

Suggest you all read what hemp is and isn’t. It certainly isn’t recreational cannabis.

The Yooya deal didn’t get off the ground bar the willingness of FFWD to sell who hold 15%.

Oh yes....:)

...is getting up to his old tricks again.

That’s very good to hear

Rich can you go long anywhere on this?

That should read further news..I’m liking the way they are playing this.

Expecting news before results

Cute but not very original.

Just put that on here to let ODonnell crew know..

Wonder what today’s news will be?

$ not £

A unicorn definition is unlisted and worth in excess of £1 billion

Would rocket on main market listing. Possible dual list on NYSE/NASDAQ?

We know Mellon has told us that Juvenescence will list on NYSE or Nasdaq